◆ Listed stock · NOVO-B.CO

Novo Nordisk

Diabète et traitements de l'obésité.

Open the chart

◆ Live market

…

24h

—

Ticker
NOVO-B.CO
Category
Stocks & ETFs
Type
Listed stock
Group
Stocks Europe
Trading hours
Market sessions

What is Novo Nordisk?

Diabète et traitements de l'obésité. A share represents part ownership of a listed company. Its price reflects investors' expectations of future earnings.

How Novo Nordisk works and what gives it value

The stock reacts to quarterly results, management guidance, sector news and the rate backdrop. Earnings releases often cause big opening gaps.

What moves the price of Novo Nordisk

  • ◆Earnings and guidance
  • ◆Interest rates
  • ◆Sector news
  • ◆Buybacks and dividends

Key metrics to watch

  • ◆Revenue growth
  • ◆Margins
  • ◆P/E ratio
  • ◆Earnings dates

Risks specific to Novo Nordisk

  • ◆Earnings disappointments
  • ◆High valuation
  • ◆Regulatory risk

How to analyse Novo Nordisk on GraphTrade

Daily and weekly; market open only during sessions. Open the NOVO-B.CO chart, add the indicators below, compare Novo Nordisk with similar assets in Performance and ask the AI Compass to explain the latest move with news and macro context.

◆ Indicators suited to Novo Nordisk

◆ FAQ

What is Novo Nordisk (NOVO-B.CO)?

Diabète et traitements de l'obésité.

Why is Novo Nordisk going up or down today?

The main drivers are: earnings and guidance, interest rates, sector news, buybacks and dividends. The AI Compass cross-references these with today's news.

Which indicators work best on Novo Nordisk?

Daily and weekly; market open only during sessions.

What are the risks of Novo Nordisk?

Earnings disappointments ; High valuation ; Regulatory risk.

How do I follow Novo Nordisk in real time?

Open the free GraphTrade chart for NOVO-B.CO: price updates live, with all indicators.

How do I add Novo Nordisk to my portfolio?

Click « Add to portfolio » on this page: the asset joins your active portfolio.

Is this investment advice?

No. GraphTrade provides information and analysis tools only.

◆ Assets similar to Novo Nordisk

Information only, not investment advice.